Safety of measles-containing vaccines in 1-year-old children
- PMID: 25560438
- DOI: 10.1542/peds.2014-1822
Safety of measles-containing vaccines in 1-year-old children
Abstract
Background and objectives: All measles-containing vaccines are associated with several types of adverse events, including seizure, fever, and immune thrombocytopenia purpura (ITP). Because the measles-mumps-rubella-varicella (MMRV) vaccine compared with the separate measles-mumps-rubella (MMR) and varicella (MMR + V) vaccine increases a toddler's risk for febrile seizures, we investigated whether MMRV is riskier than MMR + V and whether either vaccine elevates the risk for additional safety outcomes.
Methods: Study children were aged 12 to 23 months in the Vaccine Safety Datalink from 2000 to 2012. Nine study outcomes were investigated: 7 main outcomes (anaphylaxis, ITP, ataxia, arthritis, meningitis/encephalitis, acute disseminated encephalomyelitis, and Kawasaki disease), seizure, and fever. Comparing MMRV with MMR + V, relative risk was estimated by using stratified exact binomial tests. Secondary analyses examined post-MMRV or MMR + V risk versus comparison intervals; risk and comparison intervals were then contrasted for MMRV versus MMR+V.
Results: We evaluated 123,200 MMRV and 584,987 MMR + V doses. Comparing MMRV with MMR + V, risks for the 7 main outcomes were not significantly different. Several outcomes had few or zero postvaccination events. Comparing risk versus comparison intervals, ITP risk was higher after MMRV (odds ratio [OR]: 11.3 [95% confidence interval (CI): 1.9 to 68.2]) and MMR + V (OR: 10 [95% CI: 4.5 to 22.5]) and ataxia risk was lower after both vaccines (MMRV OR: 0.8 [95% CI: 0.5 to 1]; MMR + V OR: 0.8 [95% CI: 0.7 to 0.9]). Compared with MMR + V, MMRV increased risk of seizure and fever 7 to 10 days after vaccination.
Conclusions: This study did not identify any new safety concerns comparing MMRV with MMR + V or after either the MMRV or the MMR + V vaccine. This study provides reassurance that these outcomes are unlikely after either vaccine.
Keywords: measles; safety; vaccine; varicella.
Copyright © 2015 by the American Academy of Pediatrics.
Similar articles
-
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.Expert Rev Vaccines. 2023 Jan-Dec;22(1):764-776. doi: 10.1080/14760584.2023.2252065. Expert Rev Vaccines. 2023. PMID: 37642012 Review.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5. Cochrane Database Syst Rev. 2021. PMID: 34806766 Free PMC article. Review.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
-
Measles-containing vaccines and febrile seizures in children age 4 to 6 years.Pediatrics. 2012 May;129(5):809-14. doi: 10.1542/peds.2011-3198. Epub 2012 Apr 2. Pediatrics. 2012. PMID: 22473362
-
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530
Cited by
-
Adverse events following Measles-Mumps-Rubella and varicella immunization: A safety profile analysis and comparison of different vaccination schedules based on the Italian Pharmacovigilance Network in the Veneto Region.Prev Med Rep. 2024 Mar 29;41:102711. doi: 10.1016/j.pmedr.2024.102711. eCollection 2024 May. Prev Med Rep. 2024. PMID: 38606113 Free PMC article.
-
Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink.Vaccine X. 2023 Feb 4;13:100268. doi: 10.1016/j.jvacx.2023.100268. eCollection 2023 Apr. Vaccine X. 2023. PMID: 36814595 Free PMC article.
-
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.Vaccine. 2022 Apr 20;40(18):2568-2573. doi: 10.1016/j.vaccine.2022.03.031. Epub 2022 Mar 18. Vaccine. 2022. PMID: 35315325 Free PMC article.
-
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.Vaccine. 2021 Jun 23;39(28):3666-3677. doi: 10.1016/j.vaccine.2021.05.016. Epub 2021 May 14. Vaccine. 2021. PMID: 34088506 Free PMC article. Review.
-
Acute disseminated encephalomyelitis and routine childhood vaccinations - a self-controlled case series.Hum Vaccin Immunother. 2021 Aug 3;17(8):2578-2585. doi: 10.1080/21645515.2021.1901544. Epub 2021 Apr 9. Hum Vaccin Immunother. 2021. PMID: 33835888 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical